Genetic and structural basis for virus neutralization
Active Definitive Contract Awarded Last action
- Contract number
- 75N93024C00072
- Awardee
-
Vanderbilt University Medical Center UEI GYLUH9UXHDX5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,625,807
Award facts
- Opportunity
-
- Innovations in functional B cell epitope discovery Pre-Solicitation · BAANIAID75N93023R00002 · Posted May 5, 2023
- Contract value 62% obligated
-
- $4,625,807.00 Current, with exercised options
- $7,415,829.00 Potential, with all options
- Completion date 43% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Nashville, TN 37232, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $1,395,022 | |
| Change Order | $650,000 | |
| Original award | $1,395,030 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $7.415 million definitive contract to Vanderbilt University Medical Center for genetic and structural basis for virus neutralization research on September 16, 2024, with performance completion by September 15, 2029. The contract carries cost-no-fee pricing and no set-aside designation.
Place of performance is Nashville, Tennessee. The originating solicitation, posted May 5, 2023, solicited research into the genetic and structural foundations underlying virus neutralization mechanisms, informed by Executive Order 14398 guidance on pandemic preparedness.
In fiscal year 2025, the contract invoiced $1 million across 6,518 contractor hours, reflecting 3.1 FTEs at a derived government-paid hourly rate of $153.49/hr. The labor footprint includes two subcontractors contributing 29 percent of contractor hours. The Leland Stanford Junior University and the University of Texas Medical Branch at Galveston serve as subcontractors on antibody discovery Phase 1 work; Vanderbilt University's Sponsored Programs Administration division also contributes to the research effort.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| The Leland Stanford Junior University | $215,388 | |
| Vanderbilt University | $1,087 | |
| The Leland Stanford Junior University | $183,080 | |
| University Of Texas Medical Branch At Galveston | $63,238 | |
| Vanderbilt University | $19,112 | |
| Vanderbilt University | $719 | |
| Vanderbilt University | $2,371 | |
| The Leland Stanford Junior University | $215,388 | |
| Vanderbilt University | $16,247 | |
| University Of Texas Medical Branch At Galveston | $74,398 |
Quick answers
Who was awarded contract 75N93024C00072?
75N93024C00072 was awarded to Vanderbilt University Medical Center by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 16, 2024.
How much is contract 75N93024C00072 worth?
The government has obligated $4,625,807 on 75N93024C00072. Its potential value, with all options, is $7,415,829.
Was contract 75N93024C00072 competed?
The extent of competition for 75N93024C00072 was full and open competition. The government received 18 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award